cyt002-nicqb
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2003 (NCT00369616)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- nicotineImmunity, active
nicotine immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cyt002-nicqb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00369616 | Phase 2 | Dec 1, 2003 | Cantonal Hospital of St. Gallen, Cytos Biotechnology AG, Klinik Hirslanden, Zurich, University of Lausanne |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cantonal Hospital of St. Gallen | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Cytos Biotechnology AG | For profit | 1 | 1 | 1 | 2003 |
| Klinik Hirslanden, Zurich | Academic/Hospital | 1 | 0 | 1 | 2003 |
| University of Lausanne | Academic/Hospital | 1 | 0 | 1 | 2003 |
4 organizations
Page 1 / 1